Symbol: |
ST14
|
Description: |
suppression of tumorigenicity 14 (colon carcinoma) [Source:HGNC Symbol;Acc:11344]
|
Location: |
Chr11:130029457-130080356[+]
|
CRmiRSNP:
~ Export ~
|
Records:null
Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
Compound:
~ Export ~
|
Records:275
Gene |
Compound |
Gen_sig |
Exp_pattern |
ST14 |
Indeno[1,2-c]isoquinoline-5,11-dione, 6-methyl- 5-(methylsulfonyloxy)-5,6,6a,11a-tetrahydro- 2,3,8-trimethoxy-, cis- |
0.006 |
Up |
ST14 |
ANTINEOPLASTIC-376265 |
0.002 |
Down |
ST14 |
PHYTOENE |
0.034 |
Up |
ST14 |
NSC 405361 |
0.04 |
Down |
ST14 |
Neocuproin |
0.044 |
Down |
ST14 |
C.I. 37559 |
0.026 |
Up |
ST14 |
NSC 527353 |
0.02 |
Down |
ST14 |
NSC 58903 |
0.024 |
Up |
ST14 |
Camptothecin ethylglycinate ester hydrochloride |
0.018 |
Up |
ST14 |
Camptothecin hemisuccinate sodium salt |
0.013 |
Up |
ST14 |
Camptothecin lysinate HCl |
0.038 |
Up |
ST14 |
Benzo[1,2-c:4,5-c']dipyrrole-1,3,5,7(2H,6H)-tetraimine |
0.012 |
Up |
ST14 |
Carbonimidodithioic acid, [5-(4-nitrophenyl)-1,3,4- thiadiazol-2-yl]-, dimethyl ester |
0.015 |
Up |
ST14 |
2-Propen-1-one, 3-(l,3-benzodioxol-5-yl)-1-(1,4-dioxo- 2,6,7-trimethylquinoxalin-3-yl)- |
0.011 |
Up |
ST14 |
4H-1-Benzothiopyran-4-one, 2-(methylsulfonyl)- |
0.041 |
Down |
Expression pattern: Sensitivity / Resistance
Total:19 Current:4
First Prev Next Last 
|
SNP:
~ Export ~
|
Records:10
Total:1 Current:1
[First] [Prev] [Next] [Last]
|
miRNA:
~ Export ~
|
Records:37
Total:3 Current:1
[First] [Prev]  Next Last 
|